Ryan Steinberger

Executive Vice President, Chief Digital and Technology Officer · Regeneron Pharmaceuticals

Biopharmaceuticals

Ryan Steinberger is executive vice president and chief digital and technology officer of Regeneron Pharmaceuticals. He joined in 2026 after senior technology leadership at Pfizer, including oversight of digital research and development.

Last reviewed: Oct 21, 2026

Ryan Steinberger

Executive Vice President, Chief Digital and Technology Officer Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Ryan Steinberger is executive vice president and chief digital and technology officer of Regeneron Pharmaceuticals. He joined in 2026 after senior technology leadership at Pfizer, including oversight of digital research and development.

Career Highlights

  • Joined Regeneron in 2026.
  • Previously served as senior vice president of digital research and development at Pfizer.
  • Led work on enterprise AI, clinical platforms and a global ERP implementation at Pfizer.

Professional Journey

Steinberger brings more than twenty-five years of technology transformation experience to Regeneron. Before joining the company, he held senior IT leadership roles at Pfizer, working with research, manufacturing, commercial and enterprise leaders.

As Pfizer’s senior vice president of Digital Research and Development, he led initiatives involving drug discovery, clinical trials, and clinical and regulatory applications. Those efforts included cloud adoption and platform consolidation. His work also included Pfizer’s first enterprise AI strategy, technology support for COVID-19 vaccine development and a global ERP implementation.

He joined Regeneron in 2026 as executive vice president and chief Digital and Technology Officer. The appointment brings his experience across scientific systems and enterprise technology into the company’s executive leadership.

Education

Steinberger earned an MBA from Drexel University and a BS from Cornell University.